Concepedia

Wangrui Jin

WJ

Statistics

Publications

7

Citations

242

H-Index

7

Active since

2018

Affiliations

East China Normal University(Current)

Shanghai Jiao Tong University

Shanghai First People's Hospital

Texas A&M Health Science Center

Texas A&M University

Wangrui Jin is an author at East China Normal University specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

2018–2024

7

Publications

7

A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer

Tao Zhang, Jingjie Li, Yuan He et al. · Nature Communications · 2018 · 73 citations · Full text

, , +16

Inhibition of HDACs-EphA2 Signaling Axis with WW437 Demonstrates Promising Preclinical Antitumor Activity in Breast Cancer

Tao Zhang, Jingjie Li, Xiaojun Ma et al. · EBioMedicine · 2018 · 33 citations · Full text

, , +11

Update on the development of TGR5 agonists for human diseases

Wangrui Jin, Mingyue Zheng, Yihua Chen et al. · European Journal of Medicinal Chemistry · 2024 · 32 citations

, , +8

Discovery of 2-Amino-3-cyanothiophene Derivatives as Potent STAT3 Inhibitors for the Treatment of Osteosarcoma Growth and Metastasis

Wangrui Jin, Tao Zhang, Wenbo Zhou et al. · Journal of Medicinal Chemistry · 2022 · 28 citations · Full text

, , +11

Discovery of a Highly Potent and Orally Bioavailable STAT3 Dual Phosphorylation Inhibitor for Pancreatic Cancer Treatment

Peng He, Aiwu Bian, Ying Miao et al. · Journal of Medicinal Chemistry · 2022 · 28 citations · Full text

, , +11

1–5 of 7